(Updated - June 24, 2026 6:22 AM EDT)

Leerink analyst Marc Goodman initiates coverage on Rapport Therapeutics (NASDAQ: RAPP) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage